A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

NCT05113953 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Binge-Eating Disorder

Interventions

DRUG: Centanafadine
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.